Kevin G Coleman

Title: Kevin G Coleman: Innovator in Antibody Treatment Methods

Introduction

Kevin G Coleman is a prominent inventor based in Old Lyme, Connecticut, known for his significant contributions to the field of biotechnology. He holds a total of eight patents, primarily focused on treatment methods using c-Met antibodies. His work has the potential to impact various therapeutic applications, particularly in the realm of cancer treatment.

Latest Patents

Coleman's latest patents revolve around innovative methods involving c-Met antibodies. These inventions include human antibodies and antigen-binding portions that specifically bind to c-Met, with the aim of inhibiting its function. The patents also cover chimeric, bispecific, and single-chain antibodies, as well as methods for producing these antibodies. Additionally, his inventions encompass gene therapy methods utilizing nucleic acid molecules that encode the immunoglobulin molecules, along with the development of transgenic animals or plants that incorporate these nucleic acid sequences.

Career Highlights

Throughout his career, Kevin G Coleman has worked with notable companies in the biotechnology sector, including Amgen Fremont Inc. and Pfizer Corporation. His experience in these organizations has contributed to his expertise in antibody development and therapeutic applications.

Collaborations

Some of his notable coworkers include Neil R Michaud and Shama Kajiji, who have collaborated with him on various projects related to antibody research and development.

Conclusion

Kevin G Coleman is a distinguished inventor whose work in c-Met antibody treatment methods showcases his innovative spirit and dedication to advancing medical science. His contributions continue to pave the way for new therapeutic approaches in the field of biotechnology.